| Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ... The Lancet 387 (10019), 679-690, 2016 | 1945 | 2016 |
| A multi-society Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Annals of Hepatology, 101133, 2023 | 1598 | 2023 |
| Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ... PLoS medicine 11 (7), e1001680, 2014 | 733 | 2014 |
| Extrahepatic complications of nonalcoholic fatty liver disease MJ Armstrong, LA Adams, A Canbay, WK Syn Hepatology 59 (3), 1174-1197, 2014 | 708 | 2014 |
| Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study T Marjot, AM Moon, JA Cook, S Abd-Elsalam, C Aloman, MJ Armstrong, ... Journal of hepatology, 2020 | 494 | 2020 |
| Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis MJ Armstrong, D Hull, K Guo, D Barton, JM Hazlehurst, LL Gathercole, ... Journal of hepatology 64 (2), 399-408, 2016 | 448 | 2016 |
| Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort MJ Armstrong, DD Houlihan, L Bentham, JC Shaw, R Cramb, S Olliff, ... Journal of hepatology 56 (1), 234-240, 2012 | 407 | 2012 |
| Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program MJ Armstrong, DD Houlihan, IA Rowe, WHO Clausen, B Elbrønd, ... Alimentary Pharmacology & Therapeutics, 2012 | 316 | 2012 |
| High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry AM Moon, GJ Webb, C Aloman, MJ Armstrong, T Cargill, R Dhanasekaran, ... Journal of Hepatology, 2020 | 313 | 2020 |
| Mobile health use in low-and high-income countries: an overview of the peer-reviewed literature A Bastawrous, MJ Armstrong Journal of the royal society of medicine 106 (4), 130-142, 2013 | 298 | 2013 |
| Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study D Haldar, B Kern, J Hodson, MJ Armstrong, R Adam, G Berlakovich, ... Journal of hepatology, 2019 | 283 | 2019 |
| Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension D Tripathi, AJ Stanley, PC Hayes, S Travis, MJ Armstrong, EA Tsochatzis, ... Gut, 2020 | 255 | 2020 |
| Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study GJ Webb, T Marjot, JA Cook, C Aloman, MJ Armstrong, EJ Brenner, ... The Lancet Gastroenterology & Hepatology, 2020 | 247 | 2020 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The Lancet Gastroenterology & Hepatology 7 (5), 388-390, 2022 | 180 | 2022 |
| Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis R Parker, MJ Armstrong, C Corbett, IA Rowe, DD Houlihan Alimentary Pharmacology & Therapeutics, 2013 | 147 | 2013 |
| Current therapeutic strategies in non‐alcoholic fatty liver disease JK Dowman, MJ Armstrong, JW Tomlinson, PN Newsome Diabetes, Obesity and Metabolism 13 (8), 692-702, 2011 | 145 | 2011 |
| Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle JK Dowman, LJ Hopkins, GM Reynolds, N Nikolaou, MJ Armstrong, ... The American journal of pathology 184 (5), 1550-1561, 2014 | 137 | 2014 |
| Semaglutide 2· 4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial R Loomba, MF Abdelmalek, MJ Armstrong, M Jara, MS Kjær, N Krarup, ... The Lancet Gastroenterology & Hepatology, 2023 | 131 | 2023 |
| Mental health disorders and solid-organ transplant recipients C Corbett, MJ Armstrong, R Parker, K Webb, JM Neuberger Transplantation 96 (7), 593-600, 2013 | 124 | 2013 |
| SARS-CoV-2 infection in patients with autoimmune hepatitis T Marjot, G Buescher, M Sebode, E Barnes, AS Barritt IV, MJ Armstrong, ... Journal of hepatology 74 (6), 1335-1343, 2021 | 111 | 2021 |
